723. In Vivo Expansion of MDS1/EVI1, PRDM16 and SETBP1 Integration Clones in Successful Chronic Granulomatous Disease (CGD) Gene Therapy Trial.

MLA

Schwarzwaelder, Kerstin, et al. “723. In Vivo Expansion of MDS1/EVI1, PRDM16 and SETBP1 Integration Clones in Successful Chronic Granulomatous Disease (CGD) Gene Therapy Trial.” Molecular Therapy, vol. 13, June 2006, p. S279. EBSCOhost, https://doi.org/10.1016/j.ymthe.2006.08.803.

APA

Schwarzwaelder, K., Schmidt, M., Ott, M. G., Stein, S., Glimm, H., Deichmann, A., Siler, U., Hoelzer, D., Seger, R., Grez, M., & von Kalle, C. (2006). 723. In Vivo Expansion of MDS1/EVI1, PRDM16 and SETBP1 Integration Clones in Successful Chronic Granulomatous Disease (CGD) Gene Therapy Trial. Molecular Therapy, 13, S279. https://doi.org/10.1016/j.ymthe.2006.08.803

Chicago

Schwarzwaelder, Kerstin, Manfred Schmidt, Marion G. Ott, Stefan Stein, Hanno Glimm, Annette Deichmann, Ulrich Siler, et al. 2006. “723. In Vivo Expansion of MDS1/EVI1, PRDM16 and SETBP1 Integration Clones in Successful Chronic Granulomatous Disease (CGD) Gene Therapy Trial.” Molecular Therapy 13 (June): S279. doi:10.1016/j.ymthe.2006.08.803.